If they were going to, why do we have to do the CD16 trial? We showed that we are better than the SOC, reduction in hospital stay, reduced mortality, no side effects. I feel that if you show you're more effective than the SOC you should get approved, but its the FDA.
Misiu143 do you or Rockleo think leronlimab will get a EUA for covid19, or do you think time would be better spent focusing on HIV or cancer? Would you like to see a more medically experienced person as CEO to get us there?
News 
Market Data 
Discover 
